Abstract:Background During an ischemic stroke normal brain endothelial function is abrogated resulting in blood brain barrier (BBB) breakdown with subsequent infiltration of activated inflammatory blood cells, ultimately leading to neuronal cell death. Kruppel-like factor 2 (KLF2) is regulated by flow, is highly expressed in vascular endothelial cells, and serves as a key molecular switch regulating endothelial function and promoting vascular health. Purpose To determine the role of KLF2 in ischemic stroke. Methods and Results —To examine the specific role of KLF2 in the brain and cerebrovascular disease, we performed ischemic strokes and conducted BBB assays in KLF2 deficient (K2-/-), KLF2 overexpressing (K2tg), and control mice. K2 -/- mice exhibited larger strokes in the transient middle cerebral artery occlusion model (95% greater stroke volume vs. control; n=10-20/group; P=0.001) and significant impairment in BBB function as assessed by in vivo real time quantitative PET analysis and evans blue dye (EBD) assays (86% greater EBD permeability vs. control; n=3/group; P=0.002). In contrast, K2tg mice were protected against ischemic stroke (49% smaller stroke volume vs. control; n=8-9/group, P=0.004) and demonstrated less impairment in BBB function (30% less EBD permeability vs control; n=3/group; P=0.003). In concordance, gain and loss of function studies in primary brain microvascular ECs using transwell assays revealed KLF2 to be BBB protective (32% less permeability in adenoviral KLF2 overexpression vs. control; P=0.005 and 107% greater permeability in siRNA mediated KLF2 knockdown vs. control; P<0.0005). Mechanistically, KLF2 was demonstrated to regulate the critical BBB tight junction factor occludin, both in vitro (7.0±0.3 fold expression in adenoviral KLF2 overexpression vs. control; P<0.0001 and 0.43±0.03 fold expression in siRNA mediated KLF2 knockdown vs. control; P<0.0005) and in vivo (0.56±0.11 fold expression in K2 -/- vs. control; n=4-7/group; P=0.01 and 2.5±0.5 fold expression in K2tg vs. control; n=3-4/group; P<0.05). Conclusions These data are first to identify KLF2 as a key regulator of brain endothelial function and cerebrovascular homeostasis, thereby serving as a novel neuroprotective factor in ischemic stroke.

Role of lipocalin 2 in stroke

Lipocalin-2 and Cerebral Stroke

The role of lipocalin 2 in brain injury and recovery after ischemic and hemorrhagic stroke

Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke.

Mechanistic insights into Lipocalin-2 in ischemic stroke and hemorrhagic brain injury: Integrating animal and clinical studies

Effects of lipocalin-2 on brain endothelial adhesion and permeability

Neutralization of Lipocalin-2 Diminishes Stroke-Reperfusion Injury

Role of Lipocalin-2 in N1/N2 Neutrophil Polarization after Stroke

Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway

The interaction of lipocalin-2 and astrocytes in neuroinflammation: mechanisms and therapeutic application

Lipocalin-2 Mediated Polarization of Neutrophil in Cerebral Ischemia-Reperfusion Injury

Lipocalin-2 May Produce Damaging Effect after Cerebral Ischemia by Inducing Astrocytes Classical Activation

Lipocalin-2 inhibition alleviates neural injury by microglia ferroptosis suppression after experimental intracerebral hemorrhage in mice via enhancing ferritin light chain expression

Higher serum lipocalin 2 is associated with post-stroke depression at discharge

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A2 in Ischemic Stroke

Lipocalin-2 Regulates Hippocampal Microglial Activation in Poststroke Depression

Correlation between serum lipocalin-2 and white matter hyperintensities in patients with ischemic stroke

The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials

Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond

Lipocalin 2 as a Putative Modulator of Local Inflammatory Processes in the Spinal Cord and Component of Organ Cross talk After Spinal Cord Injury

Abstract WP443: KLF2 Protects Against Ischemic Stroke by Regulating Endothelial Blood Brain Barrier Function